SCHEMBL1590636

SCHEMBL1590636

CC(=O)N1CC(NS(=O)(=O)c2c(Cl)nc3n2CCS3)c2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.54
NOTUM Q6P988 3/20 0.39
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPK1 P28482 1/20 0.35
STAT3 P40763 1/20 0.35
HTT P42858 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KMT2A Q03164 3/20 0.35
PKM P14618 2/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TNKS O95271 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32
HCRTR2 O43614 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RXFP1 Q9HBX9 1/20 0.31
GAA P10253 1/20 0.31
XIAP P98170 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1591157 0.79 HTR6 (0.49) HTR6SMN1; SMN2MAPK1L3MBTL1KMT2A
SCHEMBL1590549 0.76 HTR6 (0.47) HTR6MAPK1TNKSTNKS2ALDH1A1
Hydrochloric Acid SCHEMBL1590417 0.75 HTR6 (0.46) HTR6MAPK1TNKSTNKS2
SCHEMBL1590935 0.70 HTR6 (1.00) HTR6NOTUMLMNAKMT2APKM
SCHEMBL1590226 0.70 HTR6 (0.86) HTR6PKM
Hydrochloric Acid SCHEMBL1590423 0.70 HTR6 (0.45) HTR6SMN1; SMN2MAPK1ALDH1A1GAA
SCHEMBL1591782 0.68 HTR6 (0.36) HTR6SMN1; SMN2MAPK1L3MBTL1KMT2A
SCHEMBL1590388 0.64 HTR6 (0.73) HTR6NOTUMLMNA
SCHEMBL1590218 0.64 HTR6 (0.50) HTR6SMN1; SMN2MAPK1L3MBTL1KMT2A
Hydrochloric Acid SCHEMBL1590775 0.64 HTR6 (0.49) HTR6SMN1; SMN2MAPK1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2324035-A1 SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS Laboratorios Del. Dr. Esteve, S.A. (ES) 2011-05-25 EP claimed
US-20110092540-A1 SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2011-04-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092540-A1 SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS HTR6, HTR2A, HTR4 HTR6 1/4885NOTUM 2667/4885LMNA 2741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.